Literature DB >> 11869342

Multiplicity of infection and the evolution of hybrid incompatibility in segmented viruses.

S A Frank1.   

Abstract

Some viral genomes are divided into segments. When multiple viruses infect a single cell, progeny form by reassorted mixtures of genomic segments. Hybrid incompatibilities arise when a progeny virus has incompatible segments from different parental viruses. Hybrid incompatibility has been observed in influenza and in the multiparticle plant virus Dianthovirus. Hybrid incompatibility provides an opportunity to study rates of viral evolution, divergence and speciation, and the extent of epistatic interactions among components of the viral genome. This paper presents mathematical and computer simulation models to study hybrid incompatibility between diverging strains. The models identify multiplicity of infection as a key factor. When many viral particles infect each host cell, the effective ploidy of the genetic system is high. High ploidy dilutes the contribution of each locus to the phenotype, weakening the selective intensity on each locus. Weaker selection on variant alleles allows the population to maintain greater genetic diversity and to be more easily perturbed by stochastic fluctuations. Greater diversity and stochastic fluctuations explore more widely the space of epistatic interactions, causing more frequent shifts among favoured combinations of alleles. Variable ploidy of viral genetics differs from standard Mendelian genetics.

Entities:  

Mesh:

Year:  2001        PMID: 11869342     DOI: 10.1046/j.1365-2540.2001.00911.x

Source DB:  PubMed          Journal:  Heredity (Edinb)        ISSN: 0018-067X            Impact factor:   3.821


  15 in total

1.  Density-dependent selection in vesicular stomatitis virus.

Authors:  Isabel S Novella; Daniel D Reissig; Claus O Wilke
Journal:  J Virol       Date:  2004-06       Impact factor: 5.103

2.  Fitness analyses of vesicular stomatitis strains with rearranged genomes reveal replicative disadvantages.

Authors:  Isabel S Novella; L Andrew Ball; Gail W Wertz
Journal:  J Virol       Date:  2004-09       Impact factor: 5.103

3.  Co-infection weakens selection against epistatic mutations in RNA viruses.

Authors:  Rémy Froissart; Claus O Wilke; Rebecca Montville; Susanna K Remold; Lin Chao; Paul E Turner
Journal:  Genetics       Date:  2004-09       Impact factor: 4.562

4.  Natural selection in compartmentalized environment with reshuffling.

Authors:  A S Zadorin; Y Rondelez
Journal:  J Math Biol       Date:  2019-07-13       Impact factor: 2.259

5.  Superinfection Exclusion between Two High-Risk Human Papillomavirus Types during a Coinfection.

Authors:  Jennifer Biryukov; Craig Meyers
Journal:  J Virol       Date:  2018-03-28       Impact factor: 5.103

6.  RNA Silencing May Play a Role in but Is Not the Only Determinant of the Multiplicity of Infection.

Authors:  Livia Donaire; József Burgyán; Fernando García-Arenal
Journal:  J Virol       Date:  2015-10-21       Impact factor: 5.103

7.  A viral protein mediates superinfection exclusion at the whole-organism level but is not required for exclusion at the cellular level.

Authors:  María Bergua; Mark P Zwart; Choaa El-Mohtar; Turksen Shilts; Santiago F Elena; Svetlana Y Folimonova
Journal:  J Virol       Date:  2014-07-16       Impact factor: 5.103

8.  Estimation of the effective number of founders that initiate an infection after aphid transmission of a multipartite plant virus.

Authors:  Mónica Betancourt; Alberto Fereres; Aurora Fraile; Fernando García-Arenal
Journal:  J Virol       Date:  2008-10-08       Impact factor: 5.103

9.  The multiplicity of infection of a plant virus varies during colonization of its eukaryotic host.

Authors:  Pablo González-Jara; Aurora Fraile; Tomás Canto; Fernando García-Arenal
Journal:  J Virol       Date:  2009-05-27       Impact factor: 5.103

10.  Quasispecies spatial models for RNA viruses with different replication modes and infection strategies.

Authors:  Josep Sardanyés; Santiago F Elena
Journal:  PLoS One       Date:  2011-09-19       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.